In addition to obtaining drug-specific rebate data, state and federal policymakers also need to study the contract terms between PBMs and their clients to understand the share of rebates that are passed on to payers
Weve got a very important class of compounds that are rapidly developing with many new compounds about to enter into the therapeutic arena. Meeting the Needs of Patients With T2DM: Emerging Clinical Data With GLP-1 Analogues , Medscape ******* Richard Bergenstal, MD, President for Medicine and Science, ADA
If youre affected by these, stop using the injections immediately and let your physician know
I would hope it would reduce the cost, but I cant say that I have any advanced knowledge of that or any assurance that that will happen
Although both peptides are associated with metabolic research, their mechanisms and areas of investigation reflect different stages in the development of modern peptide technologies
Your plans Evidence of Coverage will detail any coverage restrictions or rules that your drug plan may have